Executive Vice Dean and Chief Scientific Officer Glen Gaulton of the School of Medicine discusses federal funding of the sciences.
Perelman School of Medicine
Four professors from the University of Pennsylvania School of Medicine have been elected members of the Institute of Medicine (IOM), one of the nation's highest honors in biomedicine. Three of the four new inductees are women.
The new members bring Penn's total to 76, out of a total active membership of 1,649.
Overall, the IOM named 65 new members this year and foreign associates.
PHILADELPHIA –- The University of Pennsylvania’s Center for Technology Transfer has been honored with a Deal of Distinction Award by the Licensing Executive Society (USA and Canada) Inc.
The award was given for a collaborative research agreement forged earlier this year by Penn and pharmaceutical company Astra Zeneca that will make use of academic and private-industry resources to generate new Alzheimer’s disease drug candidates for clinical development.
Heart muscle cells do not normally replicate in adult tissue, but multiply with abandon during development. This is why the loss of heart muscle after a heart attack is so dire—you can’t grow enough new heart muscle to make up for the loss.
Brian Strom of the School of Medicine leads a study on electronic medical record implementation.
Penn Study: Following Traumatic Event, Early Intervention Reduces Children's PTSD Odds by 73 Percent
After experiencing a potentially traumatic event – a car accident, a physical or sexual assault, a sports injury, witnessing violence – as many as 1 in 5 children will develop Posttraumatic Stress Disorder (PTSD).
Researchers at the University of Pennsylvania School of Medicine and Immunocore Limited, Oxford, UK, today announced that a targeted agent that may have a role in treating advanced metastatic melanoma in the future has received Investigational New Drug (IND) approval and is opening enrollment for clinical trials in the UK and USA.
Click here to view the full release.